The second edition of ESC Cardio-Oncology, organised by the ESC Council of Cardio-Oncology. This landmark conference shapes the future of cardio-oncology through interdisciplinary exchange among cardiology, oncology, haematology, radiotherapy, and related fields.
ABOUT: Improving patient outcomes and preventing a cardio-oncology epidemic through collaboration and education. The conference offers a comprehensive scientific programme with a 360° view of the cardio-oncology landscape — from cutting-edge research to real-world clinical cases.
SCIENTIFIC PROGRAMME — 3 DEDICATED TRACKS:
• Cardio-Oncology for Everyday Practice: Risk stratification, cardiotoxicity surveillance, cardiac imaging, amyloidosis, and survivorship follow-up
• Advanced Cardio-Oncology: High-complexity scenarios, cardio-onco-haematology, cardiometabolic issues, CAR-T & next-gen therapies
• From Bench to Bedside: Cancer therapy–related CV toxicity mechanisms, immune checkpoint inhibitor adverse events, SGLT2 inhibitors, radiotherapy-related effects, exercise interventions
ALSO INCLUDES:
• RESILIENCE Project sessions (mental health, AI-enabled pathways, translational frontiers)
• Young Investigator Awards session
• Abstract & Clinical Case Presentations
• Interdisciplinary Joint Sessions
• Exhibition & Industry Sessions
• On-demand content until 18 July 2026
REGISTRATION FEES (incl. 10% VAT):
• Standard (Non-Member): Early €793 / Late €915 / Last Minute €1,055
• ESC Council Members: Early €610 / Late €700 / Last Minute €805
• Nurses, Allied Professionals, Students, LMIC: Early €366 / Late €420 / Last Minute €490
Early registration deadline: 22 April 2026
Late registration deadline: 19 May 2026
Hashtag: #ESCardioOnco26
Website: escardio.org/events/councils-events/esc-cardio-oncology
